What is Cyclopharm?
Founded in 2005 and headquartered in Kingsgrove, New South Wales, Cyclopharm operates within the medical and health products sector. The company engages in pharmaceutical manufacturing, serving both business-to-business and direct-to-consumer markets across Oceania. With a focus on engineering, operations, and medical technology, Cyclopharm is positioned as a key player in its industry, leveraging its public trading status and established presence.
How much funding has Cyclopharm raised?
Cyclopharm has raised a total of $13.3M across 1 funding round:
Share Placement
$13.3M
Share Placement (2024): $13.3M, investors not publicly disclosed
What's next for Cyclopharm?
The recent major strategic investment signals a pivotal growth phase for Cyclopharm. This influx of capital is likely to fuel further research and development, expansion of manufacturing capabilities, and broader market penetration. As a publicly traded entity, Cyclopharm's strategic financing moves are closely watched, indicating a commitment to scaling operations and enhancing its technological offerings in the competitive pharmaceutical landscape.
See full Cyclopharm company page
